Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: A&G PHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2019-09-13 to 2020-01-26
Current total value of award: $15417.25
Description: A&G PHARMACEUTICAL INC:1108556 [19-012467]MONOCLONAL ANTIBODY (MAB) DEVELOPMENT - `THE PURPOSE OF THIS MODIFICATION IS TO INCLUDE THE DATA RIGHTS CLAUSE IN THE SOW AND IN THE AWARD AS WELL AS REFERENCE THE ATTACHED CONFIDENTIALITY DISCLOSURE AGRE